Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia

Documenti analoghi

• Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Zanubrutinib in Immune Thrombocytopenia
  di: Qiu‐Sha Huang, et al.
  Pubblicazione: (2025)
• Megakaryopoiesis Dysregulation, Thrombocytopaenia, and Dengue Virus Pathogenesis: Molecular Mechanisms and Therapeutic Advances
  di: Preeti Sokhal, et al.
  Pubblicazione: (2025)
• The Infiltration of IL‐18‐Related Immune Cells and Their Bidirectional Regulatory Roles in the Pathogenesis of Prostate Cancer
  di: Yuqi Liu, et al.
  Pubblicazione: (2025)
• Impact of Gut Microbiota and Inflammatory Cytokines on Immune Thrombocytopenia
  di: Ji‐Gan Wang, et al.
  Pubblicazione: (2024)
• Avatrombopag for the Treatment of Immune Thrombocytopenia
  di: Caterina Labanca, et al.
  Pubblicazione: (2025)